Impact of Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) on Treatment Cost of Multiple Sclerosis: Real-World Nationwide Study
Publication date: September 2021Source: Value in Health Regional Issues, Volume 25Author(s): Katarzyna Orlewska, Krzysztof Bogusz, Aleksandra Podlecka-Piętowska, Monika Nojszewska, Mirosław Markiewicz, Robert Liwoch, Pawel Orlewski, Andrzej Śliwczyński, Beata Zakrzewska-Pniewska, Emilian Snarski
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research
More News: International Medicine & Public Health | Multiple Sclerosis | Stem Cell Therapy | Stem Cells | Study | Transplants